The company' novel drugs, used together with the new delivery system, the LODER™ (LOcal Drug EluteR), have the potential to be one of the most highly effective treatments for solid tumor cancers. Diseases that currently are included in the company's pipeline are pancreatic cancer, prostate cancer and certain brain cancers. Our Culture
View Top Employees from Silenseed LTD| Website | http://www.silenseed.com |
| Revenue | $5 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 1999 |
| Address | The Goldyne Savad Institute Of Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Jerusalem, IL |
| Phone | +972 2-674-3430 |
| Industry | Pharmaceuticals, Biotechnology, Biopharma, Drug Discovery, Healthcare, Health Care, Drug Manufacturing & Research, Science and Engineering, Therapeutics |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Silenseed LTD employee's phone or email?
Silenseed LTD Questions
The Silenseed LTD annual revenue was $5 million in 2023.
2 people are employed at Silenseed LTD.
Silenseed LTD is based in Jerusalem, Jerusalem.
The NAICS codes for Silenseed LTD are [32, 32541, 325, 3254].
The SIC codes for Silenseed LTD are [28, 283].
Top Silenseed LTD Employees
Related Companies
